Time to Deterioration: Promising Surrogate Endpoint?

In immune checkpoint inhibitor trials, time to deterioration of physical function appears to be a better surrogate for overall survival than progression-free survival, new data suggest.
Medscape Medical News

source https://www.medscape.com/viewarticle/time-deterioration-promising-surrogate-endpoint-2023a1000jmg?src=rss